Health Care/Hospital

Antengene Announces HREC Approval in Australia for the Phase I Trial of ATG-022 (Claudin 18.2 ADC) in Patients with Advanced or Metastatic Solid Tumors

* Discovered in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate targeting the Tumor Associated Antigen (TAA) Claudin 18.2 * The Phase I trial is designed to evaluate the safety, pharmacology, and preliminary efficacy of ATG-022 as a monotherapy in patients withadvanced or...

2022-12-09 08:30 497

Innovent Presents Phase Ib Clinical Data of IBI939 (Anti-TIGIT Monoclonal Antibody) in Previously Untreated PD-L1-selected NSCLC at the 2022 European Society For Medical Oncology Immuno-Oncology Congress

ROCKVILLE, Md. and SUZHOU, China, Dec 9, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-12-09 08:00 566

Innovent Presents Phase Ib Clinical Data Update of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 European Society For Medical Oncology Immuno-Oncology Congress

ROCKVILLE, Md. and SUZHOU, China, Dec. 9, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2022-12-09 08:00 571

TrialWire Awarded by Frost & Sullivan for Innovative Clinical Trial Patient Recruitment Technology Platform

TrialWire delivers superior trial patient recruitment solutions based on highly sophisticated information technology (IT) all in one secure platform SAN ANTONIO, Dec. 8, 2022 /PRNewswire/ -- Based on its recent analysis of the clinical trial patient recruitment IT solutions industry,Frost & Sulli...

2022-12-08 22:00 1570

SonarMed™ airway monitoring system Applauded by Frost & Sullivan for Providing Real-time Visualization for Accurate Troubleshooting with Its Endotracheal Tube Airway Monitor

The SonarMed™ system is the first and only FDA-cleared airway monitoring system that provides heightened patient safety, cost savings, and quality measures while lowering average LOS in the NICU. SAN ANTONIO, Dec. 8, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the neonatal care indus...

2022-12-08 21:00 699

CereCore® expands healthcare technology services into the UK

CereCore® is hiring EPR, technical and staffing expertise to work with healthcare organizations in the UK and other international locations in order to move patient record digitalisation forward. NASHVILLE, Tenn., Dec. 8, 2022 /PRNewswire/ -- CereCore today announced they are expanding their hea...

2022-12-08 20:00 761

HUISON Awarded "Four Inventions" & "Four National Patents" of Original DHA Dairy Products

XIAMEN, China, Dec. 8, 2022 /PRNewswire/ -- HUISON was awarded "Four Inventions" & "Four National Patents" of Original DHA Dairy Products: 1. Algal species patent ZL 201710398286.7: A strain of docosahexaenoic acid-producing fungi and its application; and obtained the patent for algae genetic in...

2022-12-08 11:38 1088

Amway launches Singapore Business Innovation Hub to accelerate health and wellness innovation

Hub launched in partnership with the Economic Development Board to serve as a springboard for product innovation to meet consumers' evolving wellness needs globally and also uniquely inAsia, backed by science and technology SINGAPORE, Dec. 8, 2022 /PRNewswire/ -- Amway, an entrepreneur-led health...

2022-12-08 09:30 1321

Antengene Appoints Amily Zhang as its Chief Medical Officer

SHANGHAI and HONG KONG, Dec. 8, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...

2022-12-08 08:30 1379

Mintel announces Global Food and Drink Trends for 2023

SINGAPORE, Dec. 8, 2022 /PRNewswire/ -- Mintel, the experts in what consumers want and why, has today announcedfour key trends that will shape global food and drink industries in  2023, ove...

2022-12-08 08:25 1345

HARRISON.AI NAMED ON THE 2022 CB INSIGHTS' DIGITAL HEALTH 150 LIST

The clinician-led technology platform has been recognized for achievements in computer-aided imaging NEW YORK, Dec. 8, 2022 /PRNewswire/ -- CB Insights today named harrison.ai to its fourth-annualDigital Health 150

2022-12-08 06:00 1208

Lost childhood: a 'tight-knit' network to combat abuse and distress

On Radar takes off, the first meeting of the Think Tank of Fondazione Internazionale Menarini ROME, Dec. 7, 2022 /PRNewswire/ -- Setting real changes in motion through dialogue among experts in order to tackle the unresolved issues of juvenile distress. This was the topic addressed during the fi...

2022-12-07 21:21 1812

Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by China NMPA

--The objective of Phase I clinical trial is to identify a safe and efficacious dose for the pivotal Phase II/III in COVID-19 patients. Phase I clinical trial is expected to be completed within the first quarter of 2023 --Phase I clinical trial will also determine if ASC11 needs to be boosted by ...

2022-12-07 18:10 1333

Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood

Leniolisib was well tolerated and significant improvement over placebo was notable in the co-primary endpoints, reflecting a favorable impact on patients' immune dysregulation and deficiency The peer-reviewed publication heightens international understanding of APDS, a rare and recently characte...

2022-12-07 14:00 1450

Apollo Proton Cancer Centre successfully performs Asia's 1st Brain Bypass Surgery on twin children with Moya Moya Disease

CHENNAI, India, Dec. 7, 2022 /PRNewswire/ -- Apollo Proton Cancer Centre (APCC) recently performedAsia's first brain bypass surgery on twin 8-year-old children fromthe Netherlands. The integration of advanced technology and expertise at APCC helped the children to undergo surgery and recover quic...

2022-12-07 13:17 1421

PGTG successfully develops SGF bone-derived factor to restore the skeletal system

BEIJING, Dec. 7, 2022 /PRNewswire/ -- The bone-derived skeletal growth factor (SGF), jointly developed by a research facility under the direction of leading biochemist, academician and researcher Zhao Yufen and theAnhui-based research center of one of the world's health industry leaders People's ...

2022-12-07 12:00 1192

SmartFuture launches SDK to enable plug-and-play Remote Patient Monitoring in existing healthcare payer and provider applications

SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- SmartFuture, a leading health-tech company and provider of integrated RPM (Remote Patient Monitoring) solutions, has launched anRPM SDK (Software Development Kit) product. SmartFuture's RPM SDK product allows healthcare providers and payers to integrate wh...

2022-12-07 10:36 1545

Suvoda Launches eCOA-Specific Language and Design Toolkit as Solution Moves to Second Phase of Early Adopter Program

Practical, innovative functionality seeks to alleviate eCOA burdens, reduce time-to-launch, and improve site, clinician, and patient experience. PHILADELPHIA, Dec. 7, 2022 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic ar...

2022-12-07 08:00 1258

Veeva Pulse Shows Digitally Enabled Field Teams are Using HCP Time More Effectively in Asia Pacific

HCP Access is selective as nearly half meet with only one company monthly SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the latestVeeva Pulse Field Trends Report , the largest glob...

2022-12-07 08:00 1352

Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering

SYDNEY, Dec. 7, 2022 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd (OTC Pink® Open Market: PARNF) ("Parnell") today commenced its previously announced backstopped rights offering to raise gross proceeds of approximatelyUS$4.0 million (the "Rights Offering"). Under the terms of the Rights O...

2022-12-07 07:00 1614
12345 ... 500